Lampard Inquiry to Examine Mental Health Deaths and Monitoring Technology Use

The chair of a public inquiry into mental health deaths stated that she intends to issue interim recommendations if she identifies issues that could pose an urgent risk to patient safety, according to BBC UK. Baroness Kate Lampard is currently reviewing the fatalities of more than 2,000 individuals who received care from Essex mental health services between the year 2000 and the close of 2023.

The Lampard Inquiry is scheduled to hear additional evidence during hearings commencing on October 5 before determining if recommendations are necessary prior to the release of a final report, Baroness Lampard announced. Any recommendations are anticipated to concentrate on inpatient safety, specifically addressing resuscitation protocols and the monitoring technology employed to detect patients experiencing distress.

Baroness Lampard noted that the two matters mentioned are not exclusive to Essex, meaning the evidence the inquiry hears will be relevant to service providers nationwide, and it might have consequences for the care and treatment delivered across all mental health units.

One system under review is Oxevision, which is utilized by several NHS mental health trusts in England and possesses the capability to record footage, breathing, and pulse rates. Concerns have been raised regarding this technology concerning patient dignity, privacy, and whether it could substitute for direct, face-to-face care.

Tammy Smith, whose daughter Sophie Alderman passed away in 2022, previously communicated to the inquiry that the technology removes human interaction, asserting that vulnerable individuals require conversations and someone to inquire if they are alright or if they need assistance.

LIO Health, the company behind Oxevision, stated that the technology assists in preventing serious incidents, supports staff in delivering care, and decreases the amount of time dedicated to administrative paperwork.

NHS England has stipulated that any vision-based monitoring technology must uphold a human rights-based approach to care and must be implemented in adherence to legal requirements and appropriate patient consent.

The inquiry is set to receive evidence from the Care Quality Commission, NHS England, and the Medicines and Healthcare products Regulatory Agency during hearings scheduled for October 5 through October 15. These latest sessions will be held at Chelmsford Civic Centre instead of in London, where prior hearings took place.

Families will subsequently be invited to share their perspectives on potential recommendations during a virtual hearing on October 20, before Baroness Lampard decides whether to issue interim recommendations. The final report, which may have national ramifications for mental health services across England, is not anticipated until 2028.